Smith & Nephew (SN) Shares Down 1%

Smith & Nephew plc (LON:SN) fell 1% during mid-day trading on Thursday . The company traded as low as GBX 1,309 ($17.62) and last traded at GBX 1,310 ($17.63). 2,642,030 shares traded hands during trading, a decline of 9% from the average session volume of 2,900,000 shares. The stock had previously closed at GBX 1,322.89 ($17.80).

A number of brokerages have issued reports on SN. Berenberg Bank reissued a “hold” rating and set a GBX 1,340 ($18.03) target price on shares of Smith & Nephew in a report on Friday, November 3rd. J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a GBX 1,382 ($18.60) price target on shares of Smith & Nephew in a report on Monday, November 6th. Deutsche Bank upped their price target on shares of Smith & Nephew from GBX 1,200 ($16.15) to GBX 1,315 ($17.70) and gave the stock a “hold” rating in a report on Monday, October 23rd. Jefferies Group reaffirmed a “buy” rating and issued a GBX 1,515 ($20.39) price target on shares of Smith & Nephew in a report on Thursday, October 12th. Finally, Citigroup reaffirmed a “sell” rating and issued a GBX 1,160 ($15.61) price target on shares of Smith & Nephew in a report on Thursday, October 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of GBX 1,315.82 ($17.71).

TRADEMARK VIOLATION WARNING: “Smith & Nephew (SN) Shares Down 1%” was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.com-unik.info/2017/12/07/smith-nephew-sn-shares-down-1.html.

About Smith & Nephew

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

What are top analysts saying about Smith & Nephew plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Smith & Nephew plc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit